222 related articles for article (PubMed ID: 22944598)
1. Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers.
Sousa JF; Ham AJ; Whitwell C; Nam KT; Lee HJ; Yang HK; Kim WH; Zhang B; Li M; LaFleur B; Liebler DC; Goldenring JR
Am J Pathol; 2012 Nov; 181(5):1560-72. PubMed ID: 22944598
[TBL] [Abstract][Full Text] [Related]
2. miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach.
Sousa JF; Nam KT; Petersen CP; Lee HJ; Yang HK; Kim WH; Goldenring JR
Gut; 2016 Jun; 65(6):914-24. PubMed ID: 25800782
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
4. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium.
Taupin D; Pedersen J; Familari M; Cook G; Yeomans N; Giraud AS
Lab Invest; 2001 Mar; 81(3):397-408. PubMed ID: 11310832
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.
Lee HJ; Nam KT; Park HS; Kim MA; Lafleur BJ; Aburatani H; Yang HK; Kim WH; Goldenring JR
Gastroenterology; 2010 Jul; 139(1):213-25.e3. PubMed ID: 20398667
[TBL] [Abstract][Full Text] [Related]
6. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
7. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
8. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats.
Yamaguchi H; Goldenring JR; Kaminishi M; Lee JR
Lab Invest; 2002 Aug; 82(8):1045-52. PubMed ID: 12177243
[TBL] [Abstract][Full Text] [Related]
9. Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.
Weis VG; Petersen CP; Mills JC; Tuma PL; Whitehead RH; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G777-92. PubMed ID: 25190476
[TBL] [Abstract][Full Text] [Related]
10. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
Weis VG; Sousa JF; LaFleur BJ; Nam KT; Weis JA; Finke PE; Ameen NA; Fox JG; Goldenring JR
Gut; 2013 Sep; 62(9):1270-9. PubMed ID: 22773549
[TBL] [Abstract][Full Text] [Related]
12. Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer.
Goldenring JR; Nam KT; Wang TC; Mills JC; Wright NA
Gastroenterology; 2010 Jun; 138(7):2207-10, 2210.e1. PubMed ID: 20450866
[No Abstract] [Full Text] [Related]
13. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
[TBL] [Abstract][Full Text] [Related]
14. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.
Wada T; Ishimoto T; Seishima R; Tsuchihashi K; Yoshikawa M; Oshima H; Oshima M; Masuko T; Wright NA; Furuhashi S; Hirashima K; Baba H; Kitagawa Y; Saya H; Nagano O
Cancer Sci; 2013 Oct; 104(10):1323-9. PubMed ID: 23848514
[TBL] [Abstract][Full Text] [Related]
15. Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells.
Radyk MD; Burclaff J; Willet SG; Mills JC
Gastroenterology; 2018 Mar; 154(4):839-843.e2. PubMed ID: 29248442
[TBL] [Abstract][Full Text] [Related]
16. Metaplasia in the Stomach-Precursor of Gastric Cancer?
Kinoshita H; Hayakawa Y; Koike K
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953255
[TBL] [Abstract][Full Text] [Related]
17. Gastric de novo Muc13 expression and spasmolytic polypeptide-expressing metaplasia during Helicobacter heilmannii infection.
Liu C; Smet A; Blaecher C; Flahou B; Ducatelle R; Linden S; Haesebrouck F
Infect Immun; 2014 Aug; 82(8):3227-39. PubMed ID: 24866791
[TBL] [Abstract][Full Text] [Related]
18. PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma.
Yang L; Kuang LG; Zheng HC; Li JY; Wu DY; Zhang SM; Xin Y
World J Gastroenterol; 2003 Jan; 9(1):35-9. PubMed ID: 12508347
[TBL] [Abstract][Full Text] [Related]
19. Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis.
Johnson AH; Frierson HF; Zaika A; Powell SM; Roche J; Crowe S; Moskaluk CA; El-Rifai W
Am J Pathol; 2005 Aug; 167(2):577-84. PubMed ID: 16049341
[TBL] [Abstract][Full Text] [Related]
20. A novel gastrokine, Gkn3, marks gastric atrophy and shows evidence of adaptive gene loss in humans.
Menheniott TR; Peterson AJ; O'Connor L; Lee KS; Kalantzis A; Kondova I; Bontrop RE; Bell KM; Giraud AS
Gastroenterology; 2010 May; 138(5):1823-35. PubMed ID: 20138039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
